- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Neurogenic Bladder in United Kingdom
Total 1566 results
-
University of PennsylvaniaChildren's Hospital of Philadelphia; National Center for Advancing Translational...Completed
-
GuerbetWithdrawnRenal Insufficiency | Nephrogenic Systemic FibrosisUnited States
-
Anchiano Therapeutics Israel Ltd.TerminatedNon-muscle Invasive Bladder Cancer (NMIBC)United States
-
H. Lee Moffitt Cancer Center and Research InstituteAstraZenecaTerminatedBladder Cancer | Carcinoma in Situ of BladderUnited States
-
UroGen Pharma Ltd.CompletedBladder Cancer | Urothelial Carcinoma Bladder | Urothelial CarcinomaUnited States
-
Astellas Pharma Europe B.V.CompletedUrinary Bladder, OveractiveBelgium, United States, Brazil, Canada, Denmark, Former Serbia and Montenegro, Korea, Republic of, Mexico, Norway, Philippines, Poland, South Africa, Sweden, Turkey, Ukraine, United Kingdom
-
National Institute of Diabetes and Digestive and...University of PennsylvaniaCompletedInterstitial Cystitis | Bladder DiseasesUnited States, Canada
-
Astellas Pharma IncGlaxoSmithKlineCompleted
-
Acrotech Biopharma Inc.CompletedCarcinoma, Transitional Cell | Bladder Cancer | Bladder NeoplasmSpain, France, Belgium, United States, Argentina, Croatia
-
University of Colorado, DenverNational Cancer Institute (NCI); National Institute of Diabetes and Digestive... and other collaboratorsRecruitingBladder Dysfunction | Survivors of Childhood CancerUnited States
-
PfizerCompletedUrinary Bladder, OveractiveUnited Kingdom
-
Cardiff UniversityCompletedBladder Cancer | Transitional Cell Cancer of the Renal Pelvis and Ureter | Urethral CancerUnited Kingdom
-
NovartisProcter and GambleCompletedOveractive Bladder (OAB)United States
-
Wake Forest University Health SciencesTerminatedOveractive Bladder | Lower Urinary Tract Symptoms | ConstipationUnited States
-
National Cancer Institute (NCI)RecruitingStage III Bladder Cancer AJCC v8 | Stage IV Bladder Cancer AJCC v8 | Metastatic Bladder Carcinoma | Advanced Bladder Carcinoma | Advanced Genitourinary System Carcinoma | Metastatic Genitourinary System CarcinomaUnited States
-
Theralase® Technologies Inc.University Health Network, Toronto; Pharma eMarketRecruitingNon-Muscle Invasive Bladder Cancer ("NMIBC") Unresponsive/Intolerant to BCGUnited States, Canada
-
Memorial Sloan Kettering Cancer CenterRockefeller University; Pin Down Bladder Cancer Research FoundationRecruitingNon-muscle Invasive Bladder CancerUnited States
-
Memorial Sloan Kettering Cancer CenterMerck Sharp & Dohme LLCRecruiting
-
MedtronicNeuroCompletedOveractive BladderUnited States
-
National Cancer Institute (NCI)RecruitingBladder Urothelial Carcinoma In Situ | Stage 0a Bladder Cancer AJCC v8 | Stage 0is Bladder Cancer AJCC v8 | Stage I Bladder Cancer AJCC v8 | Invasive Bladder Mixed CarcinomaUnited States, Guam, Puerto Rico
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Merck Sharp & Dohme LLC; Astellas Pharma Inc; Seagen Inc.Not yet recruitingBladder Cancer | Urothelial Carcinoma Bladder | High Grade Urothelial CarcinomaUnited States
-
Endo PharmaceuticalsTerminated
-
Mark DewhirstCompletedTransitional Cell Carcinoma of Bladder | Superficial Bladder CancerUnited States
-
State University of New York - Upstate Medical...CompletedBladder Cancer | HematuriaUnited States
-
Lantheus Medical ImagingCompletedNephrogenic Systemic FibrosisUnited States
-
PhotocureKARL STORZ Endoscopy-America, Inc.Completed
-
M.D. Anderson Cancer CenterTerminatedProstate Cancer | Bladder Cancer | Genitourinary CancerUnited States
-
Northwestern UniversityUniversity of Alberta; Ohio State University; University of CalgaryRecruitingUrologic Diseases | Overactive Bladder | Urinary Incontinence | Overactive Bladder SyndromeUnited States
-
Medstar Health Research InstituteUniversity of Oklahoma; University of Texas; Indiana UniversityCompletedOveractive Bladder | Female Sexual DysfunctionUnited States
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI)CompletedBladder CancerUnited States, Canada
-
Celldex TherapeuticsTerminated
-
Hoffmann-La RocheCompletedBladder CancerUnited States, France, Belgium, Korea, Republic of, United Kingdom, Czechia, Austria, Canada, Denmark, Greece, Italy, Netherlands, Portugal, Slovenia, Spain, Sweden, Turkey, Poland, Hungary, Switzerland, Japan, Taiwan, Australia, Norway, Germa... and more
-
CG Oncology, Inc.RecruitingBladder Cancer | Urothelial Carcinoma | Urologic Cancer | Non Muscle Invasive Bladder CancerUnited States
-
National Cancer Institute (NCI)TerminatedMetastatic Transitional Cell Cancer of the Renal Pelvis and Ureter | Recurrent Bladder Cancer | Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter | Regional Transitional Cell Cancer of the Renal Pelvis and Ureter | Stage III Bladder Cancer | Stage IV Bladder Cancer | Transitional... and other conditionsUnited States
-
Astellas Pharma Europe B.V.CompletedInterstitial Cystitis | Bladder Pain SyndromeSpain, Russian Federation, Belgium, Czechia, Germany, Hungary, Latvia, Netherlands, Poland, United Kingdom
-
University of Kansas Medical CenterNational Institutes of Health (NIH)CompletedDiabetes Mellitus | Bladder CancerUnited States
-
Benaroya Research InstituteVirginia Mason Hospital/Medical CenterUnknown
-
Christopher Patrick SmithUnknown
-
Stanford UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Not yet recruitingUrinary Incontinence | Overactive Bladder SyndromeUnited States
-
Predictive BiosciencesCompletedBladder Cancer RecurrenceUnited States
-
enGene, Inc.RecruitingSuperficial Bladder Cancer | Non-muscle Invasive Bladder Cancer With Carcinoma in SituUnited States
-
Chelsea TherapeuticsChiltern International Inc.CompletedA Clinical Study for Patients With Neurogenic Orthostatic Hypotension (NOH) Using Droxidopa (NOH301)Primary Autonomic Failure | Dopamine Beta Hydroxylase Deficiency | Symptomatic Neurogenic Orthostatic Hypotension (NOH) | Non-diabetic NeuropathyUnited States, Canada
-
Taris Biomedical LLCCompletedUrinary Bladder CancerUnited States, Netherlands
-
University of California, San FranciscoAmgenWithdrawnStage 0a Bladder Urothelial Carcinoma AJCC v6 and v7 | Stage 0is Bladder Urothelial Carcinoma AJCC v6 and v7 | Stage I Bladder Urothelial Carcinoma AJCC v6 and v7 | Stage 0 Bladder Urothelial Carcinoma AJCC v6 and v7United States
-
PfizerCompletedOveractive Bladder With Symptoms of Frequency, Urgency, and Urge Urinary IncontinenceUnited States
-
Mayo ClinicNational Cancer Institute (NCI)CompletedStage III Bladder Cancer AJCC v8 | Stage III Renal Pelvis Cancer AJCC v8 | Stage III Ureter Cancer AJCC v8 | Stage III Urethral Cancer AJCC v8 | Stage IIIA Bladder Cancer AJCC v8 | Stage IIIB Bladder Cancer AJCC v8 | Urethral Urothelial Carcinoma | Stage II Bladder Cancer AJCC v8 | Stage II Renal Pelvis... and other conditionsUnited States
-
PfizerCompletedOveractive Bladder SyndromeUnited States, Canada, Greece, Brazil, Korea, Republic of, Singapore, Poland, India, Norway, Slovakia, Spain, Belgium, Philippines, Netherlands, Sweden, Thailand, Malaysia, Germany, Colombia
-
Advanced Tactile Imaging, Inc.Princeton UrogynecologyCompleted
-
Fox Chase Cancer CenterActive, not recruitingUrothelial Carcinoma of the BladderUnited States
-
The Cleveland ClinicCompletedOveractive Bladder | Urge Incontinence | Urinary Incontinence, Urge | Overactive Bladder SyndromeUnited States